Cerner Pledges Commitment to White House Precision Medicine Initiative

KANSAS CITY, Mo., Feb. 25, 2016 (GLOBE NEWSWIRE) -- Cerner, a global leader in health care technology, announced its participation in "Sync for Science," the Obama administration's precision medicine initiative (PMI) designed to give patients the tools to donate their own health data to help improve health outcomes and treat disease.

Central to the President's PMI is development of a research cohort to engage 1 million or more Americans who would volunteer their health data for research purposes. Cerner will pilot the use of open, standardized application program interfaces to enable patients to share their electronic health record data as part of the initiative.

"Cerner is committed to helping advance precision medicine through patient-enabled research to help break down data silos," said Dr. David McCallie, senior vice president, Medical Informatics, Cerner. "It's an investment in the future of health care, which will benefit the industry overall."

Cerner is one of 30 organizations that have pledged their commitment to "Sync for Science" and will participate in the Precision Medicine Initiative Summit on Thursday, Feb. 25, at the White House.

About Cerner

Cerner's health information technologies connect people, information and systems at more than 20,000 facilities worldwide. Recognized for innovation, Cerner solutions assist clinicians in making care decisions and enable organizations to manage the health of populations. The company also offers an integrated clinical and financial system to help health care organizations manage revenue, as well as a wide range of services to support clients' clinical, financial and operational needs. Cerner's mission is to contribute to the systemic improvement of health care delivery and the health of communities. For more information about Cerner, visit, read our blog at, connect with us on Twitter at and on Facebook at Our website, blog, Twitter account and Facebook page contain a significant amount of information about Cerner, including financial and other information for investors.

BD&L Summit

Deal-Making Insights for the Life Sciences Industry

Bringing together key deal-makers and serving as an open forum for cross-functional business development and legal teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements, and M&A deals.